Thomas Kluz, Managing Director at Niterra Ventures
The most consequential shift in modern medicine isn’t happening inside hospitals or biotech labs. It’s happening inside medical simulation labs / training centers.
Drug development has long been marked…
Continue Reading
Clinical trainees face limited opportunities to practice medical history-taking skills due to scarce case diversity and access to real patients. To address this, we developed a large language model-based digital patient (LLMDP) system that…
Continue Reading
Demonstrating cardiovascular (CV) benefits with lipid-lowering therapy (LLT) requires long-term randomized clinical trials (RCTs) with thousands of patients. Innovative approaches such as in silico trials applying a disease computational model to virtual patients receiving…
Continue Reading
Virtual patients and digital patients/twins are two similar concepts gaining increasing attention in health care with goals to accelerate drug development and improve patients’ survival, but with their own limitations. Although methods have been…
Continue Reading
Coventry University is using AI to create the next generation of virtual patients, helping to teach the healthcare workers of the future – and the software is dramatically cutting the time it takes to…
Continue Reading
